Healthcare

EBOS Group (ASX:EBO) operates two main reporting segments: Healthcare and Animal Care. Its Healthcare businesses supply prescription medicines, healthcare consumables, medical devices and logistics services to pharmacies, hospitals and other providers. The segment includes Symbion and healthcare distribution, retail pharmacy brands and medical technology …

Mesoblast (ASX:MSB) uses its mesenchymal lineage cell technology platform to develop off-the-shelf treatments intended to modify inflammatory responses. Its approved product, Ryoncil (remestemcel-L-rknd), is indicated in the United States for patients aged two months and older with steroid-refractory acute graft-versus-host disease. This condition can …

Neuren Pharmaceuticals (ASX:NEU) operates through intellectual property licensing and pharmaceutical research. Acadia Pharmaceuticals holds an exclusive worldwide licence to develop and commercialise trofinetide, sold as DAYBUE in the United States for Rett syndrome. Neuren receives royalties and may receive contractual milestone payments when defined …

Clarity Pharmaceuticals (ASX:CU6) operates as a clinical-stage developer rather than a commercial pharmaceutical manufacturer. Its proprietary SAR technology attaches radioactive copper isotopes to targeting molecules, creating radiopharmaceuticals for diagnostic imaging and therapeutic applications. Copper-64 is used in imaging candidates, while copper-67 is used in …

PolyNovo (ASX:PNV) focuses on its NovoSorb biodegradable polymer technology. NovoSorb Biodegradable Temporising Matrix (BTM) is used in reconstructive treatment of wounds, while NovoSorb MTX broadens the company’s commercial product range. The company distributes products through a combination of direct sales operations and partners, including …

Australian Clinical Labs (ASX:ACL) operates a network of laboratories and collection centres providing routine and specialist testing. Its services span chemical pathology, haematology, microbiology, anatomical pathology and molecular diagnostics, alongside women’s health and reproductive screening. Referrals from general practitioners and specialists support its core …

Cogstate (ASX:CGS) supplies cognitive assessment technology and related scientific and operational services to pharmaceutical sponsors and clinical research organisations. Its work is concentrated on central nervous system research, where consistent cognitive testing and clinical endpoint quality can be important for evaluating treatments. The business …